10.3205/10DGNC221
Puchner, Maximilian J. A.
Maximilian J. A.
Puchner
Hans, Volkmar H.
Volkmar H.
Hans
Glas, Martin
Martin
Glas
Harati, Ali
Ali
Harati
Lohmann, Frauke
Frauke
Lohmann
Herrlinger, Ulrich
Ulrich
Herrlinger
Response of a recurrent anaplastic meningioma to Bevacizumab
German Medical Science GMS Publishing House
2010
ConferencePaper
610 Medical sciences; Medicine
Deutsche Gesellschaft Für Neurochirurgie
2010-09-16
2010
en
urn:nbn:de:0183-10dgnc2214
10dgnc221
text/html
61. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC) im Rahmen der Neurowoche 2010
Objective: Standard therapy for anaplastic meningiomas consists of surgery and radiotherapy. This treatment results in a median survival time of 15 months. Various attempts to treat those tumors by chemotherapeutic drugs failed. As meningiomas are highly vascularized tumors and produce high levels of[for full text, please go to the a.m. URL]
61. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC) im Rahmen der Neurowoche 2010